The Bladder Cancer Detection Kit Market is projected to reach USD 2.99 Billion by 2032
From GlobeNewswire: 2024-12-12 07:27:00
The Bladder Cancer Detection Kit Market is projected to reach USD 2.99 Billion by 2032, growing at a CAGR of 7.04% from 2024. Rising demand for early diagnostic tools, technological advancements, and the integration of AI are driving market growth. Major players include Alfa Scientific Designs, Abbott Laboratories, and Bio-Rad Laboratories.
Fluorescence in Situ Hybridization (FISH) leads the market with 46% revenue in 2023, while Enzyme-Linked Immunosorbent Assay (ELISA) is projected to grow at a CAGR of 8.26%. Hospitals dominate the market with 57% revenue, while Diagnostic Centers are set to grow at a CAGR of 8.54% from 2024 to 2032.
Cystoscopy captured 38% of the market revenue in 2023, while Urine Lab Tests are forecasted to grow at a CAGR of 8.37%. North America leads the market with 43% revenue, while the Asia Pacific region is expected to grow at a CAGR of 9.77% from 2024 to 2032.
Key developments include Pangea Laboratory’s Bladder CARE Assay earning FDA Breakthrough Device Designation and A. Menarini Diagnostics partnering with Nucleix to launch the non-invasive Bladder EpiCheck test in Europe. For more information, visit the Bladder Cancer Detection Kit Market Analysis & Outlook Report 2024-2032. Statistical insights and trends in the bladder cancer detection kit market are provided in the latest report for 2024-2032. The report includes data on incidence, prevalence, prescription trends, device volume, and healthcare spending by region in 2023. The competitive landscape, market segmentation by test type, technology, and end user, as well as regional analysis and company profiles are also covered.
For more details on the bladder cancer detection kit market analysis and outlook, access the complete report at the provided link. Buying options include a 5 reports pack for USD 7500, a 10 report pack for USD 12000, or a vertical subscription for 150 reports valid for 1 year. SNS Insider is a leading market research and consulting agency offering valuable insights for informed decision-making in a rapidly changing market environment.
Read more at GlobeNewswire: Bladder Cancer Detection Kit Market to Hit USD 2.99 Billion